Clinical Trial Update: Ketamine Infusion for Rapid Reduction of Suicidality in Pediatrics [Phase 1, Phase 2]

View source ↗

Summary

A pediatric clinical trial evaluating ketamine infusion to rapidly reduce suicidality has been terminated after Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Suicidal Ideation

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: University of British Columbia | Conditions: Suicidal Ideation | Phase 1, Phase 2 | Status: TERMINATED